The following companies saw new developments that may affect trading of their securities on Friday (Dec 8):
Thomson Medical has obtained from the Singapore Exchange an extension of one month to Jan 10, 2024 to explore options to restore the public float without suspending trading in its shares. It also set out the conditions for the grace period from the bourse operator – to continue monitoring the public float and trading activity in its shares, and to immediately request a trading halt if there is any indication of disorderly trading.
A Sasseur Reit’s wholly-owned subsidiary has extended an unsecured interest-bearing loan of 308 million yuan (S$58.1 million) from its sponsor by a year, the Reit’s manager announced on Thursday (Dec 7).
ValueMax Group has launched three commercial papers on two digital asset exchanges. It is expecting to raise between S$35 million and S$120 million in total from the unsecured short-term debts, all priced at 5 percent per annum.
Cordlife’s storage of cord blood units at its facility in Singapore “will not” be impacted by the indefinite suspension of accreditation by the Foundation for the Accreditation of Cellular Therapy, the consumer healthcare company said.
